Skip to main content
. 2010 Sep 17;10:273. doi: 10.1186/1471-2334-10-273

Table 2.

Characterization of IFN-γ ELISPOT in response to recombinant Rv1985c and the peptides mixture from ESAT-6 and CFP-10 in TB patients, LTBI and Healthy controls groups:

TB (n = 56) LTBI (n = 20) HC (n = 30)
Antigens Mean SFU
± standard error
No. positive1 Sensitivity2 (%) 95% CI (%) Mean SFU
± standard error
No. positive1 Sensitivity3 (%) 95% CI (%) Mean SFU
± standard error
No. positive1 Specificity4 (%) 95% CI (%)

Rv1985c 19.3 ± 4.7 40 71.4 57.8 to 82.7 10.0 ± 2.8 11 55 31.1 to 78.9 2.6 ± 1.1 1 96.7 82.8 to 99.9

ESAT-6 66.59 ± 9.35 46 82.16 70.6 to 91.2 37.6 ± 12.0 15 75 54.2 to 95.8 0.77 ± 0.20 0 100.0 88.4 to 100.0

CFP-10 132.8 ± 22.25 38 67.97 54.9 to 80.2 77.9 ± 24.0 15 75 54.2 to 95.8 1.0 ± 0.25 0 100.0 88.4 to 100.0

1: Positive was defined as SFU greater than or equal to 6 in 2.5 × 105 cells for ESAT-6 and CFP-10, and greater than 4.5 in 2.5 × 105 cells for Rv1985c;

2: Percentage of responding patients out of all TB patients tested;

3: Percentage of responding individuals out of all LTBI tested;

4: Percentage of true-negative healthy controls out of all healthy control individuals tested;

5: Statistically higher SFU than SFU of Rv1985c by two-tailed paired Mann-Whitney test, p < 0.001;

6: Statistical significance was determined in respect to sensitivity of Rv1985c by McNemar chi-square test, p = 0.02;

7: Not significant in respect to sensitivity of Rv1985c by McNemar chi-square test, p = 0.52.